4dmedical Ltd. · ASX:4DX
4dmedical — Corporate Update (December 2023)
7 slides from 4dmedical's corporate update, Dec 1, 2023
Slide 1: The future of lung health
The future of lung health 4DMedical Limited (ASX:4DX) Company Update 1 December 2023 Andreas Fouras CEO & Managing Director 4DMedical Limited ABN 31 161 684 831
Slide 2: Disclaimer
Disclaimer This presentation has been prepared by 4DMedical Limited (ACN 161 684 831) (Company or 4DMedical). This presentation contains summary information about the Company, its subsidiaries and the entities, businesses and assets they own and operate (Group) and their activities current as of 1 D
Slide 3: Introduction to 4DMedical
4DMedical Limited (ASX:4DX) Introduction to 4DMedical ➢ Who is 4DMedical: ▪ Software technology company commercialising its patented imaging platform, XV Technology® ▪ Allows physicians to diagnose, treat and manage patients more effectively, more efficiently and at lower cost than existing modaliti
Slide 4: XV Technology® advantages
XV Technology® advantages New medical insights Improved safety Superior results Functional insight of Comparable radiation High-detail resolution spirometry at a regional level dose to X-ray of a CT scan Patient outcomes Time efficient Low cost Improved clinical Faster, more efficient testing Compet
Slide 5: Material acceleration in commercialisation across 2Q FY2024
Material acceleration in commercialisation across 2Q FY2024 Objective: become standard of care for lung diagnosis for ventilation and perfusion Philips MoU SaaS contracts in ➢ Commercial expansion Recent developments validate Detroit & Memphis commercialisation strategy: agreement of FDA approval of
Slide 6: 4DMedical and Philips sign Memorandum of Understanding
4DMedical and Philips sign Memorandum of Understanding ➢Details: ▪ Initial focus of the partnership will be to offer 4D lung imaging as a critical screening solution for Veterans exposed to burn pits. ▪ 4DMedical’s XV Technology® will be added to Philips’ product catalogue and offered as a third-par
Slide 7: Key advisors
Board of Directors Strong board and advisory expertise support commercialisation ramp-up Key advisors Dr DAVID J. SHULKIN MD Key Advisor Highly respected physician and health care executive, Dr Shulkin was previously the Secretary of the United States Department of LIL BIANCHI Dr ANDREAS FOURAS PhD